Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000368943 | SCV000342559 | likely benign | not specified | 2016-06-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000886346 | SCV001029850 | likely benign | not provided | 2025-01-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000886346 | SCV004155826 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | CYP7A1: BS2 |
Mayo Clinic Laboratories, |
RCV000886346 | SCV004224175 | uncertain significance | not provided | 2022-09-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000886346 | SCV005223595 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003940052 | SCV004754289 | likely benign | CYP7A1-related disorder | 2021-04-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |